{
    "@context": "https://api.researchmap.jp/researcher.jsonld",
    "@id": "https://api.researchmap.jp/read0021910?format=json",
    "@type": "researchers",
    "rm:user_id": "1000060097",
    "rm:creator_id": "1000060097",
    "rm:creator_type": "myself",
    "rm:created": "2006-02-22T15:00:00Z",
    "rm:modifier_id": "1000060097",
    "rm:modifier_type": "myself",
    "rm:modified": "2024-01-17T05:10:20Z",
    "permalink": "read0021910",
    "family_name": {
        "ja": "佐藤",
        "ja-Kana": "サトウ",
        "en": "Sato"
    },
    "given_name": {
        "ja": "重一",
        "ja-Kana": "ジュウイチ",
        "en": "Juichi"
    },
    "display_name_kana": "disclosed",
    "display_nickname": "disclosed",
    "display_image": "disclosed",
    "display_contact_point": "disclosed",
    "affiliations": [
        {
            "affiliation": {
                "ja": "北海道薬科大学",
                "en": "Hokkaido Pharmaceutical University School of Pharmacy"
            },
            "section": {
                "ja": "薬学部 医療薬学科 薬剤学分野",
                "en": "Department of Pharmacy"
            },
            "job": {
                "ja": "教授"
            },
            "display_affiliation": "disclosed",
            "display_job": "disclosed",
            "rm:institution_code": "2010001004"
        }
    ],
    "degrees": [
        {
            "degree": {
                "ja": "薬学博士",
                "en": "(BLANK)"
            },
            "display_degree": "disclosed",
            "rm:institution_code": "9999999999"
        }
    ],
    "display_profile": "disclosed",
    "display_url": "disclosed",
    "identifiers": {
        "j_global_id": [
            "200901016937393220"
        ]
    },
    "rm:erad_id_verified": false,
    "rm:orc_id_verified": false,
    "display_erad_id": "closed",
    "display_orc_id": "closed",
    "display_researcher_id": "disclosed",
    "display_j_global_id": "disclosed",
    "see_also": [
        {
            "label": "j_global",
            "@id": "https://jglobal.jst.go.jp/detail?JGLOBAL_ID=200901016937393220"
        }
    ],
    "@graph": [
        {
            "@id": "https://api.researchmap.jp/read0021910/research_interests",
            "@type": "research_interests",
            "@reverse": "https://api.researchmap.jp/read0021910",
            "total_items": 4,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0021910/research_interests/1698279",
                    "@type": "research_interests",
                    "@reverse": "https://api.researchmap.jp/read0021910/research_interests",
                    "rm:id": "1698279",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "1000060097",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2006-02-22T15:00:00Z",
                    "keyword": {
                        "ja": "臨床薬物動態学"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/research_interests/1698278",
                    "@type": "research_interests",
                    "@reverse": "https://api.researchmap.jp/read0021910/research_interests",
                    "rm:id": "1698278",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "1000060097",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2006-02-22T15:00:00Z",
                    "keyword": {
                        "ja": "生物薬剤学"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/research_interests/1698277",
                    "@type": "research_interests",
                    "@reverse": "https://api.researchmap.jp/read0021910/research_interests",
                    "rm:id": "1698277",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "1000060097",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2006-02-22T15:00:00Z",
                    "keyword": {
                        "en": "Clinical Pharmacokinetics"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/research_interests/1698276",
                    "@type": "research_interests",
                    "@reverse": "https://api.researchmap.jp/read0021910/research_interests",
                    "rm:id": "1698276",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "1000060097",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2006-02-22T15:00:00Z",
                    "keyword": {
                        "en": "Biopharmaceutics"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0021910/research_areas",
            "@type": "research_areas",
            "@reverse": "https://api.researchmap.jp/read0021910",
            "total_items": 2,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0021910/research_areas/1193423",
                    "@type": "research_areas",
                    "@reverse": "https://api.researchmap.jp/read0021910/research_areas",
                    "rm:id": "1193423",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "1000060097",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2006-02-22T15:00:00Z",
                    "discipline_number": "A189",
                    "item_number": "A47040",
                    "discipline": {
                        "ja": "ライフサイエンス",
                        "en": "Life sciences"
                    },
                    "research_field": {
                        "ja": "薬理学",
                        "en": "Pharmacology"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/research_areas/1193422",
                    "@type": "research_areas",
                    "@reverse": "https://api.researchmap.jp/read0021910/research_areas",
                    "rm:id": "1193422",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "1000060097",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2006-02-22T15:00:00Z",
                    "discipline_number": "A189",
                    "item_number": "A47030",
                    "discipline": {
                        "ja": "ライフサイエンス",
                        "en": "Life sciences"
                    },
                    "research_field": {
                        "ja": "薬系衛生、生物化学",
                        "en": "Pharmaceuticals - health and biochemistry"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0021910/education",
            "@type": "education",
            "@reverse": "https://api.researchmap.jp/read0021910",
            "total_items": 2,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0021910/education/3309821",
                    "@type": "education",
                    "@reverse": "https://api.researchmap.jp/read0021910/education",
                    "rm:id": "3309821",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "1000060097",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2006-02-22T15:00:00Z",
                    "to_date": "1976",
                    "rm:institution_code": "9999999999",
                    "affiliation": {
                        "ja": "静岡薬科大学大学院"
                    },
                    "department": {
                        "ja": "薬学研究科"
                    },
                    "course": {
                        "ja": "薬剤学"
                    },
                    "address_country": "JPN"
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/education/3309822",
                    "@type": "education",
                    "@reverse": "https://api.researchmap.jp/read0021910/education",
                    "rm:id": "3309822",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "1000060097",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2006-02-22T15:00:00Z",
                    "to_date": "1974",
                    "rm:institution_code": "9999999999",
                    "affiliation": {
                        "ja": "静岡薬科大学"
                    },
                    "department": {
                        "ja": "薬学部"
                    },
                    "course": {
                        "ja": "製薬学科"
                    },
                    "address_country": "JPN"
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0021910/misc",
            "@type": "misc",
            "@reverse": "https://api.researchmap.jp/read0021910",
            "total_items": 34,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0021910/misc/15660807",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0021910/misc",
                    "rm:id": "15660807",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-27T19:20:54Z",
                    "paper_title": {
                        "en": "Effects of progesterone and norethisterone on cephalexin uptake in the human intestinal cell line Caco-2"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "K Watanabe"
                            },
                            {
                                "name": "T Jinriki"
                            },
                            {
                                "name": "J Sato"
                            }
                        ]
                    },
                    "description": {
                        "en": "Little is known about the regulatory effects of steroid hormones on the intestinal H+/oligopeptide transporter PEPT1. In the present study, we investigated the effects of progesterone and its related compounds on the uptake of cephalexin, a typical PEPT1 substrate, using the human intestinal cell line Caco-2. Caco-2 cell monolayers were cultured on plastic cell culture plates coated with rat tail collagen type I. The determination of cephalexin uptake was performed with HPLC. To investigate the effect of progesterone treatment on cephalexin uptake, the monolayers were incubated with cephalexin after progesterone treatment. Progesterone decreased cephalexin uptake in a concentration-dependent manner, and the IC50 value was calculated to be 2.3 muM. A significant decrease in cephalexin uptake was observed after progesterone treatment for 12 h, and the decrease was maximal when the monolayers were treated for 24-72 h. Cephalexin uptake was significantly inhibited by treatments with 17alpha-hydroxyprogesterone, norethisterone, and chlormadinone. By contrast, treatment with dehydroepiandrosterone, pregnenolone, estradiol, testosterone, hydrocortisone, and dexamethasone did not affect cephalexin uptake. The effects of progesterone and norethisterone treatment on the kinetic parameters of cephalexin uptake were investigated. The saturable component of cephalexin uptake was markedly inhibited by progesterone and norethisterone treatments. The J(max) of cephalexin uptake with progesterone and norethisterone treatments was significantly decreased compared with the control, whereas K-m and K-d values were not affected. Therefore the quantitative decrease in PEPT1 density is considered to be one cause of the decrease in cephalexin uptake with progesterone and norethisterone treatments."
                    },
                    "publisher": {
                        "en": "PHARMACEUTICAL SOC JAPAN"
                    },
                    "publication_date": "2004-04",
                    "publication_name": {
                        "en": "BIOLOGICAL & PHARMACEUTICAL BULLETIN"
                    },
                    "volume": "27",
                    "number": "4",
                    "starting_page": "559",
                    "ending_page": "563",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "cinii_na_id": [
                            "110003608805"
                        ],
                        "doi": [
                            "10.1248/bpb.27.559"
                        ],
                        "issn": [
                            "0918-6158"
                        ],
                        "pm_id": [
                            "15056866"
                        ],
                        "wos_id": [
                            "WOS:000220595400023"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/110003608805",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1248/bpb.27.559",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/15056866",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000220595400023&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/misc/15660781",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0021910/misc",
                    "rm:id": "15660781",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-27T19:20:54Z",
                    "paper_title": {
                        "en": "Effects of progesterone and norethisterone on cephalexin uptake in the human intestinal cell line Caco-2"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "K Watanabe"
                            },
                            {
                                "name": "T Jinriki"
                            },
                            {
                                "name": "J Sato"
                            }
                        ]
                    },
                    "description": {
                        "en": "Little is known about the regulatory effects of steroid hormones on the intestinal H+/oligopeptide transporter PEPT1. In the present study, we investigated the effects of progesterone and its related compounds on the uptake of cephalexin, a typical PEPT1 substrate, using the human intestinal cell line Caco-2. Caco-2 cell monolayers were cultured on plastic cell culture plates coated with rat tail collagen type I. The determination of cephalexin uptake was performed with HPLC. To investigate the effect of progesterone treatment on cephalexin uptake, the monolayers were incubated with cephalexin after progesterone treatment. Progesterone decreased cephalexin uptake in a concentration-dependent manner, and the IC50 value was calculated to be 2.3 muM. A significant decrease in cephalexin uptake was observed after progesterone treatment for 12 h, and the decrease was maximal when the monolayers were treated for 24-72 h. Cephalexin uptake was significantly inhibited by treatments with 17alpha-hydroxyprogesterone, norethisterone, and chlormadinone. By contrast, treatment with dehydroepiandrosterone, pregnenolone, estradiol, testosterone, hydrocortisone, and dexamethasone did not affect cephalexin uptake. The effects of progesterone and norethisterone treatment on the kinetic parameters of cephalexin uptake were investigated. The saturable component of cephalexin uptake was markedly inhibited by progesterone and norethisterone treatments. The J(max) of cephalexin uptake with progesterone and norethisterone treatments was significantly decreased compared with the control, whereas K-m and K-d values were not affected. Therefore the quantitative decrease in PEPT1 density is considered to be one cause of the decrease in cephalexin uptake with progesterone and norethisterone treatments."
                    },
                    "publisher": {
                        "en": "PHARMACEUTICAL SOC JAPAN"
                    },
                    "publication_date": "2004-04",
                    "publication_name": {
                        "en": "BIOLOGICAL & PHARMACEUTICAL BULLETIN"
                    },
                    "volume": "27",
                    "number": "4",
                    "starting_page": "559",
                    "ending_page": "563",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "cinii_na_id": [
                            "110003608805"
                        ],
                        "doi": [
                            "10.1248/bpb.27.559"
                        ],
                        "issn": [
                            "0918-6158"
                        ],
                        "pm_id": [
                            "15056866"
                        ],
                        "wos_id": [
                            "WOS:000220595400023"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/110003608805",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1248/bpb.27.559",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/15056866",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000220595400023&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/misc/15660808",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0021910/misc",
                    "rm:id": "15660808",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-26T22:52:43Z",
                    "paper_title": {
                        "en": "Studies on intestinal absorption of sulpiride (3): Intestinal absorption of sulpiride in rats"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "K Watanabe"
                            },
                            {
                                "name": "T Sawano"
                            },
                            {
                                "name": "T Jinriki"
                            },
                            {
                                "name": "J Sato"
                            }
                        ]
                    },
                    "description": {
                        "en": "The aim of this study was to investigate whether the concomitant administration of the substrates or inhibitors of PEPT1, OCTN1, OCTN2, and P-glycoprotein affects the intestinal absorption of sulpiride in rats. The absorption of sulpiride from rat intestine was decreased by the substrates or inhibitors of PEPT1, OCTN1, and OCTN2. On the other hand, the absorption was increased by the substrates of P-glycoprotein. The effects of these concomitantly administered drugs on the pharmacokinetic behavior of sulpiride after oral administration in rats were investigated. Peak concentration (C-max and area under the plasma concentration-time curve (AUC(0-8h)) of sulpiride were decreased by the concomitant administration of the substrates or inhibitors of PEPT1, OCTN1, and OCTN2. However, the same parameters were significantly increased by the concomitant administration of the substrates of P-glycoprotein. The present results suggest the possibility of drug-drug interaction during the absorption process in the small intestine due to the coad ministration of sulpiride and these agents. These findings provide important information for preventing adverse effects and for ensuring the effectiveness of sulpiride and concomitantly administered drugs."
                    },
                    "publisher": {
                        "en": "PHARMACEUTICAL SOC JAPAN"
                    },
                    "publication_date": "2004-01",
                    "publication_name": {
                        "en": "BIOLOGICAL & PHARMACEUTICAL BULLETIN"
                    },
                    "volume": "27",
                    "number": "1",
                    "starting_page": "77",
                    "ending_page": "81",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "cinii_na_id": [
                            "110003608622"
                        ],
                        "doi": [
                            "10.1248/bpb.27.77"
                        ],
                        "issn": [
                            "0918-6158"
                        ],
                        "pm_id": [
                            "14709903"
                        ],
                        "wos_id": [
                            "WOS:000187745600014"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/110003608622",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1248/bpb.27.77",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/14709903",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000187745600014&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/misc/15660783",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0021910/misc",
                    "rm:id": "15660783",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-26T22:52:43Z",
                    "paper_title": {
                        "en": "Studies on intestinal absorption of sulpiride (3): Intestinal absorption of sulpiride in rats"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "K Watanabe"
                            },
                            {
                                "name": "T Sawano"
                            },
                            {
                                "name": "T Jinriki"
                            },
                            {
                                "name": "J Sato"
                            }
                        ]
                    },
                    "description": {
                        "en": "The aim of this study was to investigate whether the concomitant administration of the substrates or inhibitors of PEPT1, OCTN1, OCTN2, and P-glycoprotein affects the intestinal absorption of sulpiride in rats. The absorption of sulpiride from rat intestine was decreased by the substrates or inhibitors of PEPT1, OCTN1, and OCTN2. On the other hand, the absorption was increased by the substrates of P-glycoprotein. The effects of these concomitantly administered drugs on the pharmacokinetic behavior of sulpiride after oral administration in rats were investigated. Peak concentration (C-max and area under the plasma concentration-time curve (AUC(0-8h)) of sulpiride were decreased by the concomitant administration of the substrates or inhibitors of PEPT1, OCTN1, and OCTN2. However, the same parameters were significantly increased by the concomitant administration of the substrates of P-glycoprotein. The present results suggest the possibility of drug-drug interaction during the absorption process in the small intestine due to the coad ministration of sulpiride and these agents. These findings provide important information for preventing adverse effects and for ensuring the effectiveness of sulpiride and concomitantly administered drugs."
                    },
                    "publisher": {
                        "en": "PHARMACEUTICAL SOC JAPAN"
                    },
                    "publication_date": "2004-01",
                    "publication_name": {
                        "en": "BIOLOGICAL & PHARMACEUTICAL BULLETIN"
                    },
                    "volume": "27",
                    "number": "1",
                    "starting_page": "77",
                    "ending_page": "81",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "cinii_na_id": [
                            "110003608622"
                        ],
                        "doi": [
                            "10.1248/bpb.27.77"
                        ],
                        "issn": [
                            "0918-6158"
                        ],
                        "pm_id": [
                            "14709903"
                        ],
                        "wos_id": [
                            "WOS:000187745600014"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/110003608622",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1248/bpb.27.77",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/14709903",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000187745600014&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/misc/15660782",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0021910/misc",
                    "rm:id": "15660782",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-27T08:31:54Z",
                    "paper_title": {
                        "en": "Effect of insulin on cephalexin uptake and transepithelial transport in the human intestinal cell line Caco-2"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "K Watanabe"
                            },
                            {
                                "name": "K Terada"
                            },
                            {
                                "name": "T Jinriki"
                            },
                            {
                                "name": "J Sato"
                            }
                        ]
                    },
                    "description": {
                        "en": "We investigated whether cephalexin transport in Caco-2 cells is regulated by insulin. After the insulin pretreatment, cephalexin uptake, and transport as well as PEPT1 mRNA and protein expression in the cells were measured. Cephalexin uptake was significantly increased by the insulin pretreatment. Insulin significantly increased cephalexin saturable uptake, but had no significant effect on the non-saturable one. PEPT1 protein expression on the apical membrane, but not PEPT1 mRNA expression, was increased by the insulin pretreatment. The enhancement of cephalexin uptake by the insulin pretreatment was inhibited by genistein, a tyrosine kinase inhibitor, and colchicine, an agent that disrupts protein translocation. Apical-to-basolateral transport of cephalexin has increased by the insulin pretreatment at the apical side and long-term insulin pretreatment at the basolateral side. It is considered that insulin mainly binds to its receptor on the apical and basolateral membranes, thereby promoting PEPT1 translocation from the intracellular pool to the apical membrane surface; consequently, PEPT1 protein expression on the apical membrane is increased. (C) 2003 Elsevier B.V. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE BV"
                    },
                    "publication_date": "2004-01",
                    "publication_name": {
                        "en": "EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES"
                    },
                    "volume": "21",
                    "number": "1",
                    "starting_page": "87",
                    "ending_page": "95",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.ejps.2003.10.002"
                        ],
                        "issn": [
                            "0928-0987"
                        ],
                        "wos_id": [
                            "WOS:000188415600009"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.ejps.2003.10.002",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000188415600009&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/misc/15660784",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0021910/misc",
                    "rm:id": "15660784",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-28T21:23:06Z",
                    "paper_title": {
                        "en": "Intestinal absorption of cephalexin in diabetes mellitus model rats"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "K Watanabe"
                            },
                            {
                                "name": "K Terada"
                            },
                            {
                                "name": "J Sato"
                            }
                        ]
                    },
                    "description": {
                        "en": "We investigated the intestinal absorption and pharmacokinetics of cephalexin, as well as the intestinal H+/oligopeptide transporter PEPT1 mRNA and protein levels in type I and type 2 diabetic rats. Cephalexin disappearance from the duodenum loop was significantly lower in streptozotocin-induced type I diabetic rats and higher in hyperinsulinemic type 2 diabetic GK and Zucker-fa/fa (Zucker) rats, than in control rats. These results were speculated to be due to the enhancement of intestinal absorption of cephalexin in GK and Zucker rats. Intestinal PEPT1 mRNA levels were not significantly different between control and diabetic rats; however, the brush-border membrane vesicle PEPT1 protein levels were increased in GK and Zucker rats. After oral administration of cephalexin, plasma cephalexin concentrations and pharmacokinetic parameters, area under the concentration versus time curve from 0 to infinity, AUC(0--&gt;infinity), and maximum plasma concentration, C-max, in GK and Zucker rats were markedly higher than in control rats. From these findings, it is considered that intestinal absorption of drugs mediated by PEPT1 may be enhanced in hyperinsulinemic type 2 diabetes mellitus rats. (C) 2003 Elsevier Science B.V. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE BV"
                    },
                    "publication_date": "2003-06",
                    "publication_name": {
                        "en": "EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES"
                    },
                    "volume": "19",
                    "number": "2-3",
                    "starting_page": "91",
                    "ending_page": "98",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/S0928-0987(03)00042-3"
                        ],
                        "issn": [
                            "0928-0987"
                        ],
                        "wos_id": [
                            "WOS:000183642700001"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/S0928-0987(03)00042-3",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000183642700001&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/misc/15660787",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0021910/misc",
                    "rm:id": "15660787",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "B000000004",
                    "rm:modifier_type": "system",
                    "rm:modified": "2006-02-22T15:00:00Z",
                    "paper_title": {
                        "en": "Inhibitory Effect of Acyl-CoA: Cholesterol Acyltransferase Inhibitor-Low Density Lipoprotein Complex on Experimental Atherosclerolis"
                    },
                    "publication_date": "2003",
                    "publication_name": {
                        "en": "Biological & Pharmaceutital Bulletin"
                    },
                    "volume": "26",
                    "number": "1",
                    "starting_page": "73",
                    "ending_page": "78",
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1248/bpb.26.73"
                        ],
                        "issn": [
                            "0918-6158",
                            "1347-5215"
                        ],
                        "cinii_na_id": [
                            "110003608293"
                        ],
                        "pm_id": [
                            "12520177"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1248/bpb.26.73",
                            "is_downloadable": false
                        },
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/110003608293",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/12520177",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/misc/15660809",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0021910/misc",
                    "rm:id": "15660809",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-02T07:20:32Z",
                    "paper_title": {
                        "en": "Studies on intestinal absorption of sulpiride (2): Transepithelial transport of sulpiride across the human intestinal cell line Caco-2"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "K Watanabe"
                            },
                            {
                                "name": "T Sawano"
                            },
                            {
                                "name": "T Endo"
                            },
                            {
                                "name": "M Sakata"
                            },
                            {
                                "name": "J Sato"
                            }
                        ]
                    },
                    "description": {
                        "en": "To determine the transport mechanism of sulpiride in an in vitro model of the human intestine, we investigated the transepithelial transport of this agent in Caco-2 cells. The transepithelial transport and intracellular accumulation of sulpiride were measured using Caco-2 cell monolayers cultured on a permeable membrane. The transepithelial transport of sulpiride in Caco-2 cells showed temperature dependence, and the transport was enhanced at weakly acidic pH on the apical side. These results demonstrate that the transepithelial transport of sulpiride is carrier mediated. To identify the drug transporter species that take part in the transepithelial transport of sulpiride, we examined the effects with the addition and preloading with specific substrates and inhibitors of various drug transporters. The results obtained from these examinations indicated that the apical-to-basolateral transport of sulpiride is mediated by the peptide transporter PEPT1, organic cation transporters OCTN1 and OCTN2 on the apical membrane, and the basolateral peptide transporter on the basolateral membrane. The basolateral-to-apical transport is mediated by the basolateral peptide transporter and organic cation transporter OCT1 on the basolateral membrane and by P-glycoprotein on the apical membrane. A decrease in the absorption of sulpiride may occur in coadministration protocols involving PEPT1-, OCTN1-, and OCTN2-transported drugs. Coadministration using the P-glycoprotein-transported drugs, in contrast, may enhance the absorption of sulpiride."
                    },
                    "publisher": {
                        "en": "PHARMACEUTICAL SOC JAPAN"
                    },
                    "publication_date": "2002-10",
                    "publication_name": {
                        "en": "BIOLOGICAL & PHARMACEUTICAL BULLETIN"
                    },
                    "volume": "25",
                    "number": "10",
                    "starting_page": "1345",
                    "ending_page": "1350",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "cinii_na_id": [
                            "110003638908"
                        ],
                        "doi": [
                            "10.1248/bpb.25.1345"
                        ],
                        "issn": [
                            "0918-6158"
                        ],
                        "pm_id": [
                            "12392092"
                        ],
                        "wos_id": [
                            "WOS:000178315600020"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/110003638908",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1248/bpb.25.1345",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/12392092",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000178315600020&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/misc/15660785",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0021910/misc",
                    "rm:id": "15660785",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-02T07:20:32Z",
                    "paper_title": {
                        "en": "Studies on intestinal absorption of sulpiride (2): Transepithelial transport of sulpiride across the human intestinal cell line Caco-2"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "K Watanabe"
                            },
                            {
                                "name": "T Sawano"
                            },
                            {
                                "name": "T Endo"
                            },
                            {
                                "name": "M Sakata"
                            },
                            {
                                "name": "J Sato"
                            }
                        ]
                    },
                    "description": {
                        "en": "To determine the transport mechanism of sulpiride in an in vitro model of the human intestine, we investigated the transepithelial transport of this agent in Caco-2 cells. The transepithelial transport and intracellular accumulation of sulpiride were measured using Caco-2 cell monolayers cultured on a permeable membrane. The transepithelial transport of sulpiride in Caco-2 cells showed temperature dependence, and the transport was enhanced at weakly acidic pH on the apical side. These results demonstrate that the transepithelial transport of sulpiride is carrier mediated. To identify the drug transporter species that take part in the transepithelial transport of sulpiride, we examined the effects with the addition and preloading with specific substrates and inhibitors of various drug transporters. The results obtained from these examinations indicated that the apical-to-basolateral transport of sulpiride is mediated by the peptide transporter PEPT1, organic cation transporters OCTN1 and OCTN2 on the apical membrane, and the basolateral peptide transporter on the basolateral membrane. The basolateral-to-apical transport is mediated by the basolateral peptide transporter and organic cation transporter OCT1 on the basolateral membrane and by P-glycoprotein on the apical membrane. A decrease in the absorption of sulpiride may occur in coadministration protocols involving PEPT1-, OCTN1-, and OCTN2-transported drugs. Coadministration using the P-glycoprotein-transported drugs, in contrast, may enhance the absorption of sulpiride."
                    },
                    "publisher": {
                        "en": "PHARMACEUTICAL SOC JAPAN"
                    },
                    "publication_date": "2002-10",
                    "publication_name": {
                        "en": "BIOLOGICAL & PHARMACEUTICAL BULLETIN"
                    },
                    "volume": "25",
                    "number": "10",
                    "starting_page": "1345",
                    "ending_page": "1350",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "cinii_na_id": [
                            "110003638908"
                        ],
                        "doi": [
                            "10.1248/bpb.25.1345"
                        ],
                        "issn": [
                            "0918-6158"
                        ],
                        "pm_id": [
                            "12392092"
                        ],
                        "wos_id": [
                            "WOS:000178315600020"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/110003638908",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1248/bpb.25.1345",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/12392092",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000178315600020&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/misc/15660810",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0021910/misc",
                    "rm:id": "15660810",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-02T07:42:44Z",
                    "paper_title": {
                        "en": "Studies on intestinal absorption of Sulpiride (1): Carrier-mediated uptake of sulpiride in the human intestinal cell line Caco-2"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "K Watanabe"
                            },
                            {
                                "name": "T Sawano"
                            },
                            {
                                "name": "K Terada"
                            },
                            {
                                "name": "T Endo"
                            },
                            {
                                "name": "M Sakata"
                            },
                            {
                                "name": "J Sato"
                            }
                        ]
                    },
                    "description": {
                        "en": "We investigated whether the uptake of a specific antipsychotic agent, sulpiride, in Caco-2 cells is mediated by a carrier-mediated system. Caco-2 cell monolayers were cultured in plastic culture dishes and uptake and efflux studies were conducted. The determination of sulpiride was performed by HPLC. At 37 degreesC, sulpiride uptake in pH 6.0 was twice as much as in pH 7.4. At 4degreesC, however, no significant difference was observed between pH 6.0 and 7.4. The uptake at 4 degreesC was markedly lower than that obtained at 37 degreesC. The subtraction of the uptake at 4 degreesC from the uptake at 37 degreesC indicated a saturable process, and the result of the Eadie-Hofstee plot analysis indicated that the uptake consists of two or more saturable components. The uptake was significantly inhibited by uncoupler, protonophore, amino acid modifying agent and proteinase. Sulpiride efflux was temperature-dependent and was significantly inhibited by uncoupler and amino acid modifying agent. These findings indicate that sulpiride uptake and efflux in Caco-2 cells are carrier-mediated. Furthermore, the uptake was significantly decreased by some substrates and inhibitors of peptide transporter, PEPT1, and organic cation transporters, OCTN1 and OCTN2, and was significantly increased by preloading with them. The uptake was also significantly increased by a typical substrate of P-glycoprotein. From these findings, we presumed that peptide transporter PEPT1 and organic cation transporters OCTN1 and OCTN2 are involved with this uptake. P-glycoprotein may also contribute to the efflux of sulpiride."
                    },
                    "publisher": {
                        "en": "PHARMACEUTICAL SOC JAPAN"
                    },
                    "publication_date": "2002-07",
                    "publication_name": {
                        "en": "BIOLOGICAL & PHARMACEUTICAL BULLETIN"
                    },
                    "volume": "25",
                    "number": "7",
                    "starting_page": "885",
                    "ending_page": "890",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "cinii_na_id": [
                            "110003638779"
                        ],
                        "doi": [
                            "10.1248/bpb.25.885"
                        ],
                        "issn": [
                            "0918-6158"
                        ],
                        "pm_id": [
                            "12132663"
                        ],
                        "wos_id": [
                            "WOS:000176492700013"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/110003638779",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1248/bpb.25.885",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/12132663",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000176492700013&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/misc/15660786",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0021910/misc",
                    "rm:id": "15660786",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-02T07:42:44Z",
                    "paper_title": {
                        "en": "Studies on intestinal absorption of Sulpiride (1): Carrier-mediated uptake of sulpiride in the human intestinal cell line Caco-2"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "K Watanabe"
                            },
                            {
                                "name": "T Sawano"
                            },
                            {
                                "name": "K Terada"
                            },
                            {
                                "name": "T Endo"
                            },
                            {
                                "name": "M Sakata"
                            },
                            {
                                "name": "J Sato"
                            }
                        ]
                    },
                    "description": {
                        "en": "We investigated whether the uptake of a specific antipsychotic agent, sulpiride, in Caco-2 cells is mediated by a carrier-mediated system. Caco-2 cell monolayers were cultured in plastic culture dishes and uptake and efflux studies were conducted. The determination of sulpiride was performed by HPLC. At 37 degreesC, sulpiride uptake in pH 6.0 was twice as much as in pH 7.4. At 4degreesC, however, no significant difference was observed between pH 6.0 and 7.4. The uptake at 4 degreesC was markedly lower than that obtained at 37 degreesC. The subtraction of the uptake at 4 degreesC from the uptake at 37 degreesC indicated a saturable process, and the result of the Eadie-Hofstee plot analysis indicated that the uptake consists of two or more saturable components. The uptake was significantly inhibited by uncoupler, protonophore, amino acid modifying agent and proteinase. Sulpiride efflux was temperature-dependent and was significantly inhibited by uncoupler and amino acid modifying agent. These findings indicate that sulpiride uptake and efflux in Caco-2 cells are carrier-mediated. Furthermore, the uptake was significantly decreased by some substrates and inhibitors of peptide transporter, PEPT1, and organic cation transporters, OCTN1 and OCTN2, and was significantly increased by preloading with them. The uptake was also significantly increased by a typical substrate of P-glycoprotein. From these findings, we presumed that peptide transporter PEPT1 and organic cation transporters OCTN1 and OCTN2 are involved with this uptake. P-glycoprotein may also contribute to the efflux of sulpiride."
                    },
                    "publisher": {
                        "en": "PHARMACEUTICAL SOC JAPAN"
                    },
                    "publication_date": "2002-07",
                    "publication_name": {
                        "en": "BIOLOGICAL & PHARMACEUTICAL BULLETIN"
                    },
                    "volume": "25",
                    "number": "7",
                    "starting_page": "885",
                    "ending_page": "890",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "cinii_na_id": [
                            "110003638779"
                        ],
                        "doi": [
                            "10.1248/bpb.25.885"
                        ],
                        "issn": [
                            "0918-6158"
                        ],
                        "pm_id": [
                            "12132663"
                        ],
                        "wos_id": [
                            "WOS:000176492700013"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/110003638779",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1248/bpb.25.885",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/12132663",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000176492700013&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/misc/15660788",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0021910/misc",
                    "rm:id": "15660788",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-16T19:21:23Z",
                    "paper_title": {
                        "en": "Inhibitory effect of dexamethasone palmitate-low density lipoprotein complex on low density lipoprotein-induced macrophage foam cell formation"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Y Tauchi"
                            },
                            {
                                "name": "Zushida, I"
                            },
                            {
                                "name": "M Yokota"
                            },
                            {
                                "name": "S Chono"
                            },
                            {
                                "name": "J Sato"
                            },
                            {
                                "name": "K Ito"
                            },
                            {
                                "name": "K Morimoto"
                            }
                        ]
                    },
                    "description": {
                        "en": "We used low density lipoprotein (LDL) as a carrier of site-specific delivery of drugs to atherosclerotic lesions, prepared a dexamethasone palmitate (DP)-LDL complex, and examined the effect of the DP-LDL complex on foam cell formation of macrophages in vitro. LDL was isolated from human plasma and the DP-LDL complex was prepared by incubation in the presence of Celite 545. The complex contained about 50 mol of DP in 1 mol of LDL. When macrophages were incubated with LDL for 48 h, cholesterol ester was accumulated in the macrophages, indicating foam cell formation. This accumulation of cholesterol ester was significantly inhibited by incubation with the DP-LDL complex. The potency of the DP-LDL complex was similar to that of dexamethasone alone. The DP-LDL complex also significantly attenuated the accumulation of cholesterol ester induced by incubation with LDL prior to the incubation with the DP-LDL complex. These findings indicated that the DP-LDL complex showed similar characteristics to LDL, and the DP-LDL complex inhibited the foam cell formation of macrophages in in vitro experiments. This DP-LDL complex has a possibility as a drug-carrier complex for use in atherosclerosis."
                    },
                    "publisher": {
                        "en": "PHARMACEUTICAL SOC JAPAN"
                    },
                    "publication_date": "2000-04",
                    "publication_name": {
                        "en": "BIOLOGICAL & PHARMACEUTICAL BULLETIN"
                    },
                    "volume": "23",
                    "number": "4",
                    "starting_page": "466",
                    "ending_page": "471",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "cinii_na_id": [
                            "110003639998"
                        ],
                        "doi": [
                            "10.1248/bpb.23.466"
                        ],
                        "issn": [
                            "0918-6158"
                        ],
                        "pm_id": [
                            "10784429"
                        ],
                        "wos_id": [
                            "WOS:000086315500019"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/110003639998",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1248/bpb.23.466",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/10784429",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000086315500019&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/misc/15660789",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0021910/misc",
                    "rm:id": "15660789",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-06T15:33:34Z",
                    "paper_title": {
                        "en": "Preparation of a complex of dexamethasone palmitate-low density lipoprotein and its effect on foam cell formation of murine peritoneal macrophages"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Y Tauchi"
                            },
                            {
                                "name": "M Takase"
                            },
                            {
                                "name": "Zushida, I"
                            },
                            {
                                "name": "S Chono"
                            },
                            {
                                "name": "J Sato"
                            },
                            {
                                "name": "K Ito"
                            },
                            {
                                "name": "K Morimoto"
                            }
                        ]
                    },
                    "description": {
                        "en": "In the early progression of atherosclerosis, LDL migrates in the subendothelial space of the artery and plays an important role in foam cell formations of macrophages. LDL may serve as a carrier of site-specific delivery of drugs to atherosclerotic lesions. In this exploratory study, dexamethasone palmitate (DP) was incorporated in LDL, and an inhibitory effect of this complex on foam cell formations was examined. LDL was isolated from human plasma, and the DP-LDL complex was prepared by incubation in the presence of Celite 545. No degradation nor modification of LDL was observed. The DP/LDL molar ratio of the complex was 35-50:1. Foam cell formations of murine macrophages were induced by incubation with oxidized LDL. When macrophages were pretreated with the DP-LDL complex, accumulation of cholesterol ester in the macrophages induced by oxidized LDL, i.e., an index of foam cell formation, was decreased. These findings indicated that the DP-LDL complex showed similar characteristics to LDL, and the DP-LDL complex inhibited foam cell formations of macrophages in vitro. This study provides the basis for further study of the DP-LDL complex as a drug-carrier complex for treatment of atherosclerosis."
                    },
                    "publisher": {
                        "en": "JOHN WILEY & SONS INC"
                    },
                    "publication_date": "1999-07",
                    "publication_name": {
                        "en": "JOURNAL OF PHARMACEUTICAL SCIENCES"
                    },
                    "volume": "88",
                    "number": "7",
                    "starting_page": "709",
                    "ending_page": "714",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "cinii_na_id": [
                            "80011213047"
                        ],
                        "doi": [
                            "10.1021/js980422v"
                        ],
                        "issn": [
                            "0022-3549"
                        ],
                        "pm_id": [
                            "10393569"
                        ],
                        "wos_id": [
                            "WOS:000081322800008"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/80011213047",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1021/js980422v",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/10393569",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000081322800008&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/misc/15660811",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0021910/misc",
                    "rm:id": "15660811",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "B000000004",
                    "rm:modifier_type": "system",
                    "rm:modified": "2006-02-22T15:00:00Z",
                    "paper_title": {
                        "ja": "パルミチン酸デキサメタゾン含有脂肪乳剤の粥状動脈硬化症に対する有用性"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "丁野純男"
                            },
                            {
                                "name": "田内義彦"
                            },
                            {
                                "name": "佐藤重一"
                            },
                            {
                                "name": "伊藤圭二"
                            },
                            {
                                "name": "鈴木正夫"
                            },
                            {
                                "name": "森本一洋"
                            }
                        ]
                    },
                    "publication_date": "1999",
                    "publication_name": {
                        "ja": "Drug Delivery System"
                    },
                    "volume": "14",
                    "number": "6",
                    "starting_page": "511",
                    "ending_page": "515",
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.2745/dds.14.511"
                        ],
                        "issn": [
                            "0913-5006",
                            "1881-2732"
                        ],
                        "cinii_na_id": [
                            "10007339086"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.2745/dds.14.511",
                            "is_downloadable": false
                        },
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/10007339086",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/misc/15660806",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0021910/misc",
                    "rm:id": "15660806",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-08-29T22:36:20Z",
                    "paper_title": {
                        "en": "Effects of dexamethasone palmitate incorporated lipid emulsion on the experimental atherosclerosis"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Sumio Chono"
                            },
                            {
                                "name": "Toshihiko Tauchi"
                            },
                            {
                                "name": "Juichi Sato"
                            },
                            {
                                "name": "Keiji Ito"
                            },
                            {
                                "name": "Masao Suzuki"
                            },
                            {
                                "name": "Kazuhiro Morimoto"
                            }
                        ]
                    },
                    "description": {
                        "en": "The effects of dexamethasone palmitate incorpo rated into lipid emulsion(D-lipo) on foam cell for mation and atherosclerosis model mice were examined. The cholesterol ester (CE) concentration in derived macrophages from mouse peritoneal cavity was increased markedly by oxidized LDL. The CE increment was associated with conversion of macrophages to foam cell. D-lipo significantly inhibited the CE increment on macrophages induced by oxidized LDL. The inhibition effect of D-lipo on foam cell formation was similar with that of dex amethasone phosphate as control. The atherogenic mouse was induced by the maintaining with an atherogenic diet for 14 weeks. D-lipo or dexameth asone phosphate was intravenously administered to mouse once a week from 8 to 14 weeks. The choles terol concentration in serum and aortic CE deposition on the atherogenic mouse were significantly increased as compared to those of the control mouse. Although the increment of cholesterol con centration in serum was not changed, CE accumulation in the aorta of atherogenic mouse was inhibited by D-lipo (150 and 750 nmol/kg). Dexamethasone phosphate (750 nmol/kg) did not affect to choles terol concentration in serum and CE accumulation in the aorta of atherogenic mouse. These findings suggest that D-lipo is useful as an anti-atherosclerosis. © 1999, THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM. All rights reserved."
                    },
                    "publication_date": "1999",
                    "publication_name": {
                        "en": "Drug Delivery System"
                    },
                    "volume": "14",
                    "number": "6",
                    "starting_page": "511",
                    "ending_page": "515",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.2745/dds.14.511"
                        ],
                        "issn": [
                            "1881-2732",
                            "0913-5006"
                        ],
                        "scopus_id": [
                            "34548449493"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.2745/dds.14.511",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/misc/15660792",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0021910/misc",
                    "rm:id": "15660792",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-16T08:36:06Z",
                    "paper_title": {
                        "en": "Urinary excretion of mefenamic acid and its metabolites including their esterglucuronides in preterm infants undergoing mefenamic acid therapy"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "J Sato"
                            },
                            {
                                "name": "N Kudo"
                            },
                            {
                                "name": "E Owada"
                            },
                            {
                                "name": "K Ito"
                            },
                            {
                                "name": "Y Niida"
                            },
                            {
                                "name": "M Umetsu"
                            },
                            {
                                "name": "T Kikuta"
                            },
                            {
                                "name": "K Ito"
                            }
                        ]
                    },
                    "description": {
                        "en": "Urinary excretion of mefenamic acid (MA) and its two oxidative metabolites, M-I (3'-hydroxymethyl derivative) and M-II (3'-carboxyl derivative), and their glucuronides was investigated in preterm infants undergoing MA therapy. MA was given orally at a dose of 2 mg/kg and the dose was repeated every 24 h a maximum of three times. Urine was collected for up to 5 d after the last dose, and MA and the metabolites mere determined by a newly developed HPLC. The cumulative amounts of MA and the metabolites excreted in the urine varied from 7 to 46% of the total dose administered, and mere less than those reported in adults and children. Significant correlation was observed between the plasma half-life of MA and the cumulative amount of MA and the metabolites excreted in the urine. These results suggest that long plasma half-lives of MA observed in preterm infants are due mainly to low activity of drug metabolizing enzyme(s). In an infant who received the two regimens of MA therapy about 2 weeks apart, the plasma half-life of MA was shortened and the urinary excretion of the MA metabolites including their glucuronides was greatly increased during this period. It is suggested that the activities of both cytochrome P-450(s) and glucuronyltransferase(s) related to MA metabolism rapidly increased during the first month of the infant's life."
                    },
                    "publisher": {
                        "en": "PHARMACEUTICAL SOC JAPAN"
                    },
                    "publication_date": "1997-04",
                    "publication_name": {
                        "en": "BIOLOGICAL & PHARMACEUTICAL BULLETIN"
                    },
                    "volume": "20",
                    "number": "4",
                    "starting_page": "443",
                    "ending_page": "445",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "cinii_na_id": [
                            "110003639074"
                        ],
                        "doi": [
                            "10.1248/bpb.20.443"
                        ],
                        "issn": [
                            "0918-6158"
                        ],
                        "pm_id": [
                            "9145227"
                        ],
                        "wos_id": [
                            "WOS:A1997WU87900030"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/110003639074",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1248/bpb.20.443",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/9145227",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:A1997WU87900030&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/misc/15660791",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0021910/misc",
                    "rm:id": "15660791",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-16T03:19:08Z",
                    "paper_title": {
                        "en": "Simple, rapid and sensitive method for the determination of indomethacin in plasma by high-performance liquid chromatography with ultraviolet detection"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "J Sato"
                            },
                            {
                                "name": "T Amizuka"
                            },
                            {
                                "name": "Y Niida"
                            },
                            {
                                "name": "M Umetsu"
                            },
                            {
                                "name": "K Ito"
                            }
                        ]
                    },
                    "description": {
                        "en": "A micro method for determination of indomethacin in plasma was developed, Following deproteinization of plasma with acetonitrile containing internal standard (mefenamic acid), the separation of indomethacin and internal standard was achieved by high-performance liquid chromatography using a 7 mu m LiChrosorb-RP18 column (250 x 4 mm I.D.) at 50 degrees C. The mobile phase was 6 mM phosphoric acid-acetonitrile (50:50). The flow-rate was kept at 2.0 ml/min and the column effluent was monitored at 205 nm. The coefficients of variation of the method estimated at 0.2 and 1.0 mu g/ml were 4.2 and 2.3%, and the detection limit of the drug was about 0.05 mu g/ml (S/N=5). The method requires minimum pretreatment of the plasma with a small sample volume (25 mu l), and is very suitable far therapeutic drug monitoring of indomethacin in premature infants with symptomatic patent ductus arteriosus."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE BV"
                    },
                    "publication_date": "1997-04",
                    "publication_name": {
                        "en": "JOURNAL OF CHROMATOGRAPHY B"
                    },
                    "volume": "692",
                    "number": "1",
                    "starting_page": "241",
                    "ending_page": "244",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "cinii_na_id": [
                            "10024514561"
                        ],
                        "doi": [
                            "10.1016/S0378-4347(96)00463-X"
                        ],
                        "issn": [
                            "0378-4347"
                        ],
                        "wos_id": [
                            "WOS:A1997WY40900033"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/10024514561",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/S0378-4347(96)00463-X",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:A1997WY40900033&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/misc/15660812",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0021910/misc",
                    "rm:id": "15660812",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2022-08-19T05:42:52Z",
                    "paper_title": {
                        "ja": "高速液体クロマトグラフィーによる血清中塩酸ピルジカイニドの定量とTDMへの応用",
                        "en": "Determination of Pilsicainide Hydrochloride in Serum by High-Performance Liquid Chromatography and Its Application to TDM"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "GOTOH YOSHIKAZU"
                            },
                            {
                                "name": "CHIKUSHI NORIFUMI"
                            },
                            {
                                "name": "YUHKI YOSHIMITSU"
                            },
                            {
                                "name": "TADANO KOHJI"
                            },
                            {
                                "name": "HAYASHI TOSHIYUKI"
                            },
                            {
                                "name": "SATO JUICHI"
                            },
                            {
                                "name": "ITO KEIJI"
                            },
                            {
                                "name": "TAKAHASHI YASUSHI"
                            }
                        ],
                        "ja": [
                            {
                                "name": "後藤 仁和"
                            },
                            {
                                "name": "築紫 憲文"
                            },
                            {
                                "name": "結城 祥充"
                            },
                            {
                                "name": "唯野 貢司"
                            },
                            {
                                "name": "林 俊之"
                            },
                            {
                                "name": "佐藤 重一"
                            },
                            {
                                "name": "伊藤 圭二"
                            },
                            {
                                "name": "高橋 保志"
                            }
                        ]
                    },
                    "description": {
                        "ja": "A micro method for the determination of pilsicainide hydrochloride, an antiarrhythmic agent, in human serum was developed. In this method, serum containing the drug was extracted with benzene under alkaline conditions and then the extract was analyzed by high-performance liquid chromatography using a 5 mm Shim-pack HRC-CN column (150 mmX4.6 mm I.D.) at 40℃The mobile phase was 65 mM sodium perchlorate-acetonitrile (85 : 15). The flow-rate was kept at 1 .2 ml/min and the column effluent was monitored at 200 nm. Lidocaine hydrochloride or disopiramide phosphate was used as an internal standard. The method is accurate and reproducible for routine monitoring of serum pilsicainide hydrochloride. The serum levels of pilsicainide hydrochloride in 30 patients monitored at 1.2 to 15.5 hrs after the last dose prior to blood sampling varied from 0.18 to 1.52μg/ml. Relatively large interindividual differences were observed in the apparent total body clearances and elimination half-Iives estimated using a computer program (PEDAL). We recommend that the serum levels of pilsicainide hydrochloride be monitored in patients receiving this drug therapy.",
                        "en": "A micro method for the determination of pilsicainide hydrochloride, an antiarrhythmic agent, in human serum was developed. In this method, serum containing the drug was extracted with benzene under alkaline conditions and then the extract was analyzed by high-performance liquid chromatography using a 5 mm Shim-pack HRC-CN column (150 mmX4.6 mm I.D.) at 40℃The mobile phase was 65 mM sodium perchlorate-acetonitrile (85 : 15). The flow-rate was kept at 1 .2 ml/min and the column effluent was monitored at 200 nm. Lidocaine hydrochloride or disopiramide phosphate was used as an internal standard. The method is accurate and reproducible for routine monitoring of serum pilsicainide hydrochloride. The serum levels of pilsicainide hydrochloride in 30 patients monitored at 1.2 to 15.5 hrs after the last dose prior to blood sampling varied from 0.18 to 1.52μg/ml. Relatively large interindividual differences were observed in the apparent total body clearances and elimination half-Iives estimated using a computer program (PEDAL). We recommend that the serum levels of pilsicainide hydrochloride be monitored in patients receiving this drug therapy."
                    },
                    "publisher": {
                        "ja": "日本病院薬剤師会"
                    },
                    "publication_date": "1997",
                    "publication_name": {
                        "ja": "病院薬学"
                    },
                    "volume": "23",
                    "number": "5",
                    "starting_page": "460",
                    "ending_page": "466",
                    "languages": [
                        "jpn"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0389-9098",
                            "2185-9477"
                        ],
                        "cinii_na_id": [
                            "110001799687"
                        ],
                        "cinii_nc_id": [
                            "AN00002794"
                        ],
                        "doi": [
                            "10.5649/jjphcs1975.23.460"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "cinii_articles",
                            "@id": "http://ci.nii.ac.jp/naid/110001799687",
                            "is_downloadable": false
                        },
                        {
                            "label": "cinii_books",
                            "@id": "http://ci.nii.ac.jp/ncid/AN00002794",
                            "is_downloadable": false
                        },
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.5649/jjphcs1975.23.460",
                            "is_downloadable": false
                        },
                        {
                            "label": "url",
                            "@id": "http://dl.ndl.go.jp/info:ndljp/pid/10561932",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/misc/15660790",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0021910/misc",
                    "rm:id": "15660790",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "B000000004",
                    "rm:modifier_type": "system",
                    "rm:modified": "2006-02-22T15:00:00Z",
                    "paper_title": {
                        "en": "Determination of Pilsicainide Hydrochloride in Serum by High-Performance Liquid Chromatography and Its Application to TDM"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "YOSHIKAZU GOTOH"
                            },
                            {
                                "name": "NORIFUMI CHIKUSHI"
                            },
                            {
                                "name": "YOSHIMITSU YUHKI"
                            },
                            {
                                "name": "KOHJI TADANO"
                            },
                            {
                                "name": "TOSHIYUKI HAYASHI"
                            },
                            {
                                "name": "JUICHI SATO"
                            },
                            {
                                "name": "KEIJI ITO"
                            },
                            {
                                "name": "YASUSHI TAKAHASHI"
                            }
                        ]
                    },
                    "publication_date": "1997",
                    "publication_name": {
                        "en": "Japanese Journal of Hospital Pharmacy"
                    },
                    "volume": "23",
                    "number": "5",
                    "starting_page": "460",
                    "ending_page": "466",
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.5649/jjphcs1975.23.460"
                        ],
                        "issn": [
                            "0389-9098",
                            "2185-9477"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.5649/jjphcs1975.23.460",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/misc/15660793",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0021910/misc",
                    "rm:id": "15660793",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "1000060097",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2006-02-22T15:00:00Z",
                    "paper_title": {
                        "en": "Pharmacokinetics of mefenamic acid in preterm infants with patent ductus arteriosus."
                    },
                    "publication_date": "1994",
                    "publication_name": {
                        "en": "Acta Paediatrica Japonica"
                    },
                    "volume": "36",
                    "number": "4",
                    "starting_page": "387",
                    "ending_page": "391",
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0021910/association_memberships",
            "@type": "association_memberships",
            "@reverse": "https://api.researchmap.jp/read0021910",
            "total_items": 6,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0021910/association_memberships/1791041",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0021910/association_memberships",
                    "rm:id": "1791041",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "1000060097",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2006-02-22T15:00:00Z",
                    "academic_society_name": {
                        "ja": "シクロデキストリン学会"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/association_memberships/1791040",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0021910/association_memberships",
                    "rm:id": "1791040",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "1000060097",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2006-02-22T15:00:00Z",
                    "academic_society_name": {
                        "ja": "日本薬物動態学会"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/association_memberships/1791039",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0021910/association_memberships",
                    "rm:id": "1791039",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "1000060097",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2006-02-22T15:00:00Z",
                    "academic_society_name": {
                        "ja": "日本新生児学会"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/association_memberships/1791038",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0021910/association_memberships",
                    "rm:id": "1791038",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "1000060097",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2006-02-22T15:00:00Z",
                    "academic_society_name": {
                        "ja": "日本DDS学会"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/association_memberships/1791037",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0021910/association_memberships",
                    "rm:id": "1791037",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "1000060097",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2006-02-22T15:00:00Z",
                    "academic_society_name": {
                        "ja": "日本薬剤学会"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/association_memberships/1791036",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0021910/association_memberships",
                    "rm:id": "1791036",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "1000060097",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2006-02-22T15:00:00Z",
                    "academic_society_name": {
                        "ja": "日本薬学会"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0021910/research_projects",
            "@type": "research_projects",
            "@reverse": "https://api.researchmap.jp/read0021910",
            "total_items": 6,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0021910/research_projects/2634982",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/read0021910/research_projects",
                    "rm:id": "2634982",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "1000060097",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2006-02-22T15:00:00Z",
                    "research_project_title": {
                        "ja": "薬物の体内動態と輸送担体に関する研究"
                    },
                    "from_date": "1999",
                    "overall_grant_amount": {
                        "indirect_cost": "0",
                        "total_cost": "0",
                        "direct_cost": "0"
                    },
                    "fund_type": "competitive_research_funding"
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/research_projects/2634979",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/read0021910/research_projects",
                    "rm:id": "2634979",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "1000060097",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2006-02-22T15:00:00Z",
                    "research_project_title": {
                        "en": "Studies on drug disposition and drug transporters"
                    },
                    "from_date": "1999",
                    "overall_grant_amount": {
                        "indirect_cost": "0",
                        "total_cost": "0",
                        "direct_cost": "0"
                    },
                    "fund_type": "competitive_research_funding"
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/research_projects/2634984",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/read0021910/research_projects",
                    "rm:id": "2634984",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "1000060097",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2006-02-22T15:00:00Z",
                    "research_project_title": {
                        "ja": "新生児における薬物の体内動態に関する研究"
                    },
                    "overall_grant_amount": {
                        "indirect_cost": "0",
                        "total_cost": "0",
                        "direct_cost": "0"
                    },
                    "fund_type": "competitive_research_funding"
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/research_projects/2634983",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/read0021910/research_projects",
                    "rm:id": "2634983",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "1000060097",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2006-02-22T15:00:00Z",
                    "research_project_title": {
                        "ja": "特定組織への選択的薬物送達に関する研究"
                    },
                    "overall_grant_amount": {
                        "indirect_cost": "0",
                        "total_cost": "0",
                        "direct_cost": "0"
                    },
                    "fund_type": "competitive_research_funding"
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/research_projects/2634981",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/read0021910/research_projects",
                    "rm:id": "2634981",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "1000060097",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2006-02-22T15:00:00Z",
                    "research_project_title": {
                        "en": "Studies on drug disposition in newborn infants"
                    },
                    "overall_grant_amount": {
                        "indirect_cost": "0",
                        "total_cost": "0",
                        "direct_cost": "0"
                    },
                    "fund_type": "competitive_research_funding"
                },
                {
                    "@id": "https://api.researchmap.jp/read0021910/research_projects/2634980",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/read0021910/research_projects",
                    "rm:id": "2634980",
                    "rm:user_id": "1000060097",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000060097",
                    "rm:creator_type": "myself",
                    "rm:created": "2006-02-22T15:00:00Z",
                    "rm:modifier_id": "1000060097",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2006-02-22T15:00:00Z",
                    "research_project_title": {
                        "en": "Studies on site-specific drug delivery"
                    },
                    "overall_grant_amount": {
                        "indirect_cost": "0",
                        "total_cost": "0",
                        "direct_cost": "0"
                    },
                    "fund_type": "competitive_research_funding"
                }
            ]
        }
    ]
}